BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38244874)

  • 1. Prospective Analysis of Radiation-Induced Contrast Enhancement and Health-Related Quality of Life After Proton Therapy for Central Nervous System and Skull Base Tumors.
    Lütgendorf-Caucig C; Pelak M; Hug E; Flechl B; Surböck B; Marosi C; Mock U; Zach L; Mardor Y; Furman O; Hentschel H; Gora J; Fossati P; Stock M; Graichen U; Klee S; Georg P
    Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1206-1216. PubMed ID: 38244874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis.
    Dutz A; Agolli L; Baumann M; Troost EGC; Krause M; Hölscher T; Löck S
    Acta Oncol; 2019 Jun; 58(6):916-925. PubMed ID: 30882264
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-Term Clinical Safety of High-Dose Proton Radiation Therapy Delivered With Pencil Beam Scanning Technique for Extracranial Chordomas and Chondrosarcomas in Adult Patients: Clinical Evidence of Spinal Cord Tolerance.
    Stieb S; Snider JW; Placidi L; Kliebsch U; Lomax AJ; Schneider RA; Weber DC
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):218-225. PubMed ID: 29029887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors.
    Pehlivan B; Ares C; Lomax AJ; Stadelmann O; Goitein G; Timmermann B; Schneider RA; Hug EB
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1432-40. PubMed ID: 22349042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation Necrosis and White Matter Lesions in Pediatric Patients With Brain Tumors Treated With Pencil Beam Scanning Proton Therapy.
    Bojaxhiu B; Ahlhelm F; Walser M; Placidi L; Kliebsch U; Mikroutsikos L; Morach P; Bolsi A; Lomax T; Pica A; Weber DC
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):987-996. PubMed ID: 29485079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.
    Grosshans DR; Zhu XR; Melancon A; Allen PK; Poenisch F; Palmer M; McAleer MF; McGovern SL; Gillin M; DeMonte F; Chang EL; Brown PD; Mahajan A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):540-6. PubMed ID: 25304948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Endoscopic Evaluation of Acute Radiation Esophagitis during Chemoradiotherapy with Proton Beam Therapy Boost for Esophageal Cancer.
    Hasatani K; Tamamura H; Yamamoto K; Aoyagi H; Miyanaga T; Kaizaki Y; Sawada T
    Digestion; 2020; 101(4):366-374. PubMed ID: 31067539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.
    Fang P; Mick R; Deville C; Both S; Bekelman JE; Christodouleas JP; Guzzo TJ; Tochner Z; Hahn SM; Vapiwala N
    Cancer; 2015 Apr; 121(7):1118-27. PubMed ID: 25423899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brainstem Injury in Pediatric Patients With Posterior Fossa Tumors Treated With Proton Beam Therapy and Associated Dosimetric Factors.
    Gentile MS; Yeap BY; Paganetti H; Goebel CP; Gaudet DE; Gallotto SL; Weyman EA; Morgan ML; MacDonald SM; Giantsoudi D; Adams J; Tarbell NJ; Kooy H; Yock TI
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):719-729. PubMed ID: 29413284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.
    Parikh RR; Rhome R; Hug E; Tsai H; Cahlon O; Chon B; Goenka A
    Clin Lung Cancer; 2016 Sep; 17(5):362-366. PubMed ID: 27372386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of adolescents and young adults treated for brain and skull base tumors with pencil beam scanning proton therapy.
    Lim PS; Tran S; Kroeze SGC; Pica A; Hrbacek J; Bachtiary B; Walser M; Leiser D; Lomax AJ; Weber DC
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28664. PubMed ID: 32881313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity.
    Gordon K; Gulidov I; Koryakin S; Smyk D; Makeenkova T; Gogolin D; Lepilina O; Golovanova O; Semenov A; Dujenko S; Medvedeva K; Mardynsky Y
    Radiat Oncol; 2021 Dec; 16(1):238. PubMed ID: 34930352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.
    Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Ishikawa Y; Azami Y; Kato T; Tsukiyama I; Kikuchi Y; Hareyama M; Murakami M; Fuwa N; Hata M; Inoue T
    Radiat Oncol; 2014 Jan; 9():26. PubMed ID: 24422711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy.
    Ludmir EB; Mahajan A; Paulino AC; Jones JY; Ketonen LM; Su JM; Grosshans DR; McAleer MF; McGovern SL; Lassen-Ramshad YA; Adesina AM; Dauser RC; Weinberg JS; Chintagumpala MM
    Neuro Oncol; 2019 May; 21(5):686-695. PubMed ID: 30753704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer.
    Cuaron JJ; Chon B; Tsai H; Goenka A; DeBlois D; Ho A; Powell S; Hug E; Cahlon O
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):284-91. PubMed ID: 25754632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal Substructure Dosimetry Predicts Corneal Toxicity in Patients With Uveal Melanoma Treated With Proton Beam Therapy.
    Lee HJ; Stacey A; Klesert TR; Wells C; Skalet AH; Bloch C; Fung A; Bowen SR; Wong TP; Shibata D; Halasz LM; Rengan R
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):374-382. PubMed ID: 30763658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late toxicity of proton beam therapy for patients with the nasal cavity, para-nasal sinuses, or involving the skull base malignancy: importance of long-term follow-up.
    Zenda S; Kawashima M; Arahira S; Kohno R; Nishio T; Tahara M; Hayashi R; Akimoto T
    Int J Clin Oncol; 2015 Jun; 20(3):447-54. PubMed ID: 25135461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multidisciplinary Orbit-Sparing Treatment Approach That Includes Proton Therapy for Epithelial Tumors of the Orbit and Ocular Adnexa.
    Holliday EB; Esmaeli B; Pinckard J; Garden AS; Rosenthal DI; Morrison WH; Kies MS; Gunn GB; Fuller CD; Phan J; Beadle BM; Zhu XR; Zhang X; Frank SJ
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):344-352. PubMed ID: 26454680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chest wall toxicity after hypofractionated proton beam therapy for liver malignancies.
    Yeung R; Bowen SR; Chapman TR; MacLennan GT; Apisarnthanarax S
    Pract Radiat Oncol; 2018; 8(4):287-293. PubMed ID: 29452863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic radiation-induced rectal injury after adjuvant radiotherapy for pelvic malignant tumors: report based on a phase 3 randomized clinical trial].
    Zhou Y; Huang H; Wan T; Feng YL; Liu JH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):962-968. PubMed ID: 34823296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.